Pediatric antimicrobial therapy. II.
D001419:Bacteria / Q000187:drug effects*; D003091:Colistin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004358:Drug Therapy; D004917:Erythromycin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects; D004977:Ethambutol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D005839:Gentamicins / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D007612:Kanamycin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D010372:Pediatrics
D005839:Gentamicins; D007612:Kanamycin; D004917:Erythromycin; D004977:Ethambutol; D007538:Isoniazid; D003091:Colistin